Hope for IPF cough: experimental drug shows promise in early trial
Symptom relief
Completed
This study tested a drug called orvepitant to see if it can reduce chronic coughing in people with idiopathic pulmonary fibrosis (IPF), a serious lung disease. About 80 adults with IPF and persistent cough took either orvepitant or a placebo in two separate periods, and researche…
Phase: PHASE2 • Sponsor: Nerre Therapeutics Ltd. • Aim: Symptom relief
Last updated Jun 27, 2026 07:56 UTC